Member Info for chrishutch

Oversold and bottomed

chris akers
@sportschris
27m
MelodyVR your all-access-pass to live music in virtual reality and launching tomorrow 22nd August on Oculus Quest the world’s fastest selling wireless VR headset with remote controllers. Music will never look and hear the same again.
@oculus
@facebook
?@melodyvirtual
? #EVRH

could not agree more re take over target. Will be on many radars I imagine.

Of course the link for http://labskintattoo.com/

and of course they will no doubt be testing big pharmas skin creams on their labgrown only commercially available skin type, to prove which companies creams stand up to the claims they make and which are snake oil sales mans. Medicine, beauty treatments etc will get a lot more transparent in the future and the rush for the big companies to prove their claims is on.

https://www.labskin.co.uk/world-psoriasis-day-october-29th/

Thankfully we are invested in the 'go-to company'

It all stems off the WoundPhase product which is already in the shops. No doubt Gerard and the team are working on using and adapting the technology/science to exploit the most lucrative and hopefully also the products that give something back to the world.

https://integumen.com/?s=woundphase

WoundPhase
'Visual diagnostic wound dressing that changes colour to indicate infection or improvement of the wound under the dressing'

Appreciate the response chillfinger. That is kind of you. Sadly the family member is also wheat, gluten, etc, etc, intolerant and has colitis, IBS, etc. Really feel for her. So she is a bit of a gut expert. The strangest thing is her psoriasis really flares up with stress. Thankfully private health care and a long way down the road now but she has tried everything that 'claims' to help no matter the cost. So you can see how any product that helped or signalled and could prove those 'claims' would be a gold mine.

Drinking beetroot seems to have a real advantage. Maybe I should invent a beetroot cream and get integument to test it for me, haha.

Still, we know the uv tattoos are moving forward at a rate and I believe with a bit of luck might even be in the shops 2020. This would be a huge addition to the growing revenue streams.

the journey north starts.

guessing you think there is a chunk of upside here. You have a habit of picking winners!

gave me lots funds to spread around during the summer lows though, been buying SKIN, TLOU, INFA, NCCL, ROCK amongst others, waiting for the market to turn and carry them up for me. I like this EVRH though, anything with facebook mentioned in RNS is golden.

Hi, Sadly not. I took profit at RBD not because I think anything negative about the company but simply because it was my largest investment and it more than doubled. The risk of leaving it on the table was too much for me. Wish holders there all the best though.

Morning Kiwi.

Looking good again, above 7 today

When the market turns and it will turn - this will move up with it. Great value at present.

I actually bought more shares than I intended because the price sub 6p is so good.

Bugs lol buys

Seems possible there are bugs in the back ground as I could sell at the ask and above at times during the day.

Not that it matters because as I said before I am in for the longer term and want to see the James Bond stuff come to fruition.

I really think assuming they can be produced cheap that the uv safety tattoos could be huge. Can see the Australian gov who already do a lot for sun protection amongst children being very interested.

As for the acne and psoriasis Versions could also be a gold mine. I have fAmily members who suffer and they will try ever cream, potion, thing, no matter the cost to end the suffering.

And these are not even the core business. Which all by itself is very impressive.

There has been lots of talk about the share price but when a company is this amazing and has so many potential revenue streams it would be nice if discussion was about its products and services.

That’s the spirit James. Lol.

wow

CF73 @CF73P0
5d
#NCCL Top four significant holders have 41.5% of stock between them. Probably a number of holders we don't know about in the 1% to 2% range. Committed LTHs possibly account for another 15%. Free float dwindling while fundamentals strengthening post JDA. Not long for the re-rate.